A. Hilditch

522 total citations
22 papers, 366 citations indexed

About

A. Hilditch is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Hilditch has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Hilditch's work include Receptor Mechanisms and Signaling (9 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Renin-Angiotensin System Studies (6 papers). A. Hilditch is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Renin-Angiotensin System Studies (6 papers). A. Hilditch collaborates with scholars based in United Kingdom. A. Hilditch's co-authors include G.M. Drew, Robert J. Naylor, Mark J. Robertson, Kenneth L. Clark, Eric T. Whalley, Christine Förster, Gerhard Levy, Barry C. Ross, David Middlemiss and Sarah L. Dallas and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Trends in Pharmacological Sciences and British Journal of Pharmacology.

In The Last Decade

A. Hilditch

21 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hilditch United Kingdom 12 210 172 114 99 49 22 366
Andrew J. Bilski United Kingdom 5 265 1.3× 168 1.0× 98 0.9× 128 1.3× 27 0.6× 8 441
Kathryn Gradin Sweden 12 148 0.7× 178 1.0× 90 0.8× 130 1.3× 44 0.9× 32 381
Anjaneyulu S. Tadepalli United States 12 197 0.9× 211 1.2× 118 1.0× 129 1.3× 39 0.8× 23 463
Mizue Suzuki‐Kusaba Japan 12 178 0.8× 124 0.7× 122 1.1× 148 1.5× 47 1.0× 46 378
C. Böhmann Germany 12 184 0.9× 112 0.7× 138 1.2× 58 0.6× 47 1.0× 15 350
E. Reit United States 8 179 0.9× 129 0.8× 156 1.4× 72 0.7× 36 0.7× 15 396
L. -H. Tung Australia 10 143 0.7× 98 0.6× 138 1.2× 99 1.0× 46 0.9× 15 335
Paul H. Volkman United States 7 155 0.7× 170 1.0× 54 0.5× 73 0.7× 37 0.8× 9 376
O Aprigliano Italy 8 207 1.0× 131 0.8× 100 0.9× 162 1.6× 28 0.6× 9 367
Wendy Hope Australia 14 175 0.8× 191 1.1× 59 0.5× 106 1.1× 33 0.7× 23 462

Countries citing papers authored by A. Hilditch

Since Specialization
Citations

This map shows the geographic impact of A. Hilditch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hilditch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hilditch more than expected).

Fields of papers citing papers by A. Hilditch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hilditch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hilditch. The network helps show where A. Hilditch may publish in the future.

Co-authorship network of co-authors of A. Hilditch

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hilditch. A scholar is included among the top collaborators of A. Hilditch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hilditch. A. Hilditch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilditch, A., et al.. (1997). Effects of the angiotensin AT1 receptor antagonist GR138950 on haemodynamic function in dogs. Journal of Autonomic Pharmacology. 17(1). 1–11. 2 indexed citations
2.
Hilditch, A., Helen Prior, & G.M. Drew. (1996). Further investigations into the mechanism of the antihypertensive activity of the angiotensin AT1 receptor antagonist, GR138950. British Journal of Pharmacology. 118(3). 711–719. 5 indexed citations
3.
Hilditch, A., G.M. Drew, David Middlemiss, et al.. (1995). Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 272(2). 750–757. 22 indexed citations
4.
Hilditch, A., C. Gardner, D.J. Twissell, et al.. (1994). Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist. British Journal of Pharmacology. 111(1). 137–144. 21 indexed citations
5.
Middlemiss, David, Steve P. Watson, Barry C. Ross, et al.. (1993). Benzofuran based angiotensi II antagonists related to GR117289: Part II; amino acid amides. Bioorganic & Medicinal Chemistry Letters. 3(10). 2043–2046. 3 indexed citations
6.
Clark, Kenneth L., A. Hilditch, Mark J. Robertson, & G.M. Drew. (1991). Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.. PubMed. 9(12). 1143–50. 20 indexed citations
7.
Clark, Kenneth L., G.M. Drew, & A. Hilditch. (1989). Potentiation of the effects of dopamine in the rabbit isolated splenic artery by 3-isobutyl-l-methylxanthine or forskolin. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(5). 533–40. 5 indexed citations
8.
Hilditch, A. & G.M. Drew. (1987). Subclassification of Peripheral Dopamine Receptors. Clinical and Experimental Hypertension Part A Theory and Practice. 9(5-6). 853–872. 15 indexed citations
9.
Dallas, Sarah L., G.M. Drew, & A. Hilditch. (1986). Effects of Dopamine Receptor Agonists and Antagonists at Peripheral Neuronal and Vascular Dopamine Receptors in the Anaesthetised Cat. Journal of Cardiovascular Pharmacology. 8(1). 116–125. 8 indexed citations
10.
Hilditch, A. & G.M. Drew. (1985). Peripheral dopamine receptor subtypes — a closer look. Trends in Pharmacological Sciences. 6. 396–400. 47 indexed citations
11.
Hilditch, A. & G.M. Drew. (1984). Effects of Dopamine Receptor Agonists and Antagonists at Peripheral Neuronal and Vascular Dopamine Receptors in the Anaesthetised Dog. Journal of Cardiovascular Pharmacology. 6(3). 460–469. 10 indexed citations
12.
Drew, G.M., et al.. (1984). Presynaptic α‐adrenoceptors: do exogenous and neuronally released noradrenaline act at different sites?. British Journal of Pharmacology. 81(3). 457–464. 21 indexed citations
13.
Drew, G.M. & A. Hilditch. (1984). Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle. British Journal of Pharmacology. 83(4). 871–881. 12 indexed citations
14.
Hilditch, A., G.M. Drew, & Robert J. Naylor. (1984). SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors. European Journal of Pharmacology. 97(3-4). 333–334. 49 indexed citations
15.
Förster, Christine, G.M. Drew, A. Hilditch, & Eric T. Whalley. (1983). Dopamine receptors in human basilar arteries. European Journal of Pharmacology. 87(2-3). 227–235. 25 indexed citations
16.
Hilditch, A. & G.M. Drew. (1981). Characteristics of the dopamine receptors in the rabbit isolated splenic artyery. European Journal of Pharmacology. 72(4). 287–296. 40 indexed citations
17.
Drew, G.M., A. Hilditch, & Gerhard Levy. (1979). The Relationships Between the Cardiovascular Effects, α- and β-Adrenoceptor Blocking Actions and Plasma Concentration of Labetalol in Doca Hypertensive Rats. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(5). 597–611. 8 indexed citations
18.
Drew, G.M., A. Hilditch, & Gerhard Levy. (1978). EFFECT OF LABETALOL ON THE UPTAKE OF [3H]‐(‐)‐NORADRENALINE INTO THE ISOLATED VAS DEFERENS OF THE RAT. British Journal of Pharmacology. 63(3). 471–474. 11 indexed citations
19.
Hilditch, A., et al.. (1978). An improved device for the direct recording of blood pressure in conscious dogs. Journal of Pharmacological Methods. 1(1). 89–90. 1 indexed citations
20.
Conway, James, et al.. (1974). Effect of Propranolol on Blood Pressure in Normal and Hypertensive Rats. Clinical Science. 48(s2). 101s–103s. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Bilski Breakdown of academic impact, for papers by Kathryn Gradin Breakdown of academic impact, for papers by Anjaneyulu S. Tadepalli Breakdown of academic impact, for papers by Mizue Suzuki‐Kusaba Breakdown of academic impact, for papers by C. Böhmann Breakdown of academic impact, for papers by E. Reit Breakdown of academic impact, for papers by L. -H. Tung Breakdown of academic impact, for papers by Paul H. Volkman Breakdown of academic impact, for papers by O Aprigliano Breakdown of academic impact, for papers by Wendy Hope
Rankless by CCL
2026